2017
DOI: 10.1007/s11060-017-2382-3
|View full text |Cite
|
Sign up to set email alerts
|

N-(p-coumaroyl) serotonin inhibits glioblastoma cells growth through triggering S-phase arrest and apoptosis

Abstract: Glioblastoma is the most common and most malignant primary brain tumor with a median survival of 15 months. N-(p-coumaroyl) serotonin (CS) is an indole alkaloid with antioxidant, cardioprotective effects after ischemia and antitumor activity. In the present study we sought to determine whether could exert cytotoxic and cytostatic effects in glioma cells in vitro. CS was tested for toxicity in zebrafish. We investigated the effect of CS in U251MG and T98G glioblastoma cell lines. Viability and proliferation of … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
15
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(17 citation statements)
references
References 30 publications
2
15
0
Order By: Relevance
“…To further explore the mechanism of α-CBD on hepatocellular carcinoma cells, the cell cycle and gene expression in HepG2 cells were detected. The results of flow cytometry demonstrated that α-CBD inhibited the proliferation of hepatocarcinoma cells at the S phase, which is consistent with the results of previous research showing that other antitumor compounds can induce G2/M arrest in human cancer cells [28,29]. Transcriptome profiling demonstrated that these differential genes are related to cell attachment, cell migration, mitosis, cell cycle, DNA strand extension in DNA replication, growth factor binding, protein localization, metal ion transition, cell death, programmed cell death, apoptosis progression, the apoptosis pathway, ubiquitin transferase activity, endoplasmic reticulum signaling pathway, and protein transport, all of which can promote apoptosis.…”
Section: Discussionsupporting
confidence: 91%
“…To further explore the mechanism of α-CBD on hepatocellular carcinoma cells, the cell cycle and gene expression in HepG2 cells were detected. The results of flow cytometry demonstrated that α-CBD inhibited the proliferation of hepatocarcinoma cells at the S phase, which is consistent with the results of previous research showing that other antitumor compounds can induce G2/M arrest in human cancer cells [28,29]. Transcriptome profiling demonstrated that these differential genes are related to cell attachment, cell migration, mitosis, cell cycle, DNA strand extension in DNA replication, growth factor binding, protein localization, metal ion transition, cell death, programmed cell death, apoptosis progression, the apoptosis pathway, ubiquitin transferase activity, endoplasmic reticulum signaling pathway, and protein transport, all of which can promote apoptosis.…”
Section: Discussionsupporting
confidence: 91%
“…Our research group has been working towards novel therapeutics of GBM, which are based on natural products. Specifically, on the basis of experimental results that include FC methodologies, we have found that difluoromethylornithine (DFMO) [ 96 ] as well as the natural substances moschamine [ 97 ], n-p-coumaroyl-serotonin [ 98 ], and deglucohellebrin [ 99 ] exhibit significant antiglioma activity in vitro and low cytotoxity in vivo, as shown in a zebrafish embryo model.…”
Section: Flow Cytometry For Study Of Anticancer Agent Efficacymentioning
confidence: 99%
“…DNA content analysis revealed several mechanisms of action for different antiglioma agents. For example, N-(p-coumaroyl)-serotonin resulted in both S and G2/M phase arrest, moschamine resulted mostly in S phase arrest and deglucohellebrin in G2/M phase arrest [ 97 , 98 , 99 ]. Several other studies have used in DNA content analysis quantification in several CNSM treatments, revealing, among others, the antiglioma effects of curcumin [ 100 ], quercetin [ 101 ], glycyrrhizic acid [ 102 ], and palbociclib [ 103 ].…”
Section: Flow Cytometry For Study Of Anticancer Agent Efficacymentioning
confidence: 99%
“…Safflower seeds contain various flavonoids including serotonin, N-(p-coumaroyl) serotonin, N-feruloyl serotonin, luteolin, and luteolin-7-O-glucoside. However, N-(pcoumaroyl) serotonin and N-feruloyl serotonin are the most abundant flavonoids in safflower seed, and they have been used to treat cancer, cardiovascular diseases, and obesity [21,24,25,[35][36][37]. p-Coumaroyl serotonin and N-feruloyl serotonin are used to treat diabetes [36].…”
Section: Discussionmentioning
confidence: 99%
“…Serotonin, a flavonoid compound, is present as N-(p-coumaroyl) serotonin and N-feruloyl serotonin in safflower seeds. N-Feruloyl serotonin reduces the oxidation of low-density lipoproteins associated with the inflammatory processes of atherosclerosis [18], whereas N-(p-coumaroyl) serotonin has been used to prevent and treat bone diseases, cardiovascular diseases, glioma, and obesity [24][25][26]. N-(p-Coumaroyl) serotonin has been demonstrated to reduce oxidation and suppress inflammatory cytokine expression by inhibiting the NF-κB signaling pathway [27].…”
Section: Introductionmentioning
confidence: 99%